Cargando…

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells

The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is effective in the treatment of human chronic lymphocytic leukaemia and mantle cell lymphoma. Recent data have shown that ibrutinib also blocks IgE‐dependent activation and histamine release in human basophils (BAs) and mast cells (MCs). T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gamperl, Susanne, Stefanzl, Gabriele, Peter, Barbara, Smiljkovic, Dubravka, Bauer, Karin, Willmann, Michael, Valent, Peter, Hadzijusufovic, Emir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900099/ https://www.ncbi.nlm.nih.gov/pubmed/31286638 http://dx.doi.org/10.1111/vco.12520

Ejemplares similares

In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2020)

Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms
por: Willmann, Michael, et al.
Publicado: (2018)

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
por: Peter, Barbara, et al.
Publicado: (2017)

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
por: Schneeweiss, Mathias, et al.
Publicado: (2018)

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V(+) Neoplastic Mast Cells
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2022)

Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal
por: Willmann, Michael, et al.
Publicado: (2021)

BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils
por: Smiljkovic, D., et al.
Publicado: (2017)

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis
por: Berger, Daniela, et al.
Publicado: (2021)

NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation
por: Hadzijusufovic, E, et al.
Publicado: (2012)

Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myeloma
por: Blatt, Katharina, et al.
Publicado: (2016)

The uptake of 5-hydroxytryptamine, histamine, and their amino acid precursors by neoplastic mast cells.
por: Green, J. P.
Publicado: (1966)

Engraftment in NSG(SCF) mice correlates with the WHO category and prognosis in systemic mastocytosis
por: Willmann, Michael, et al.
Publicado: (2023)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph(+) Chronic Myeloid Leukemia
por: Sadovnik, Irina, et al.
Publicado: (2022)

CYTOLOGICAL AND PHARMACOLOGICAL OBSERVATIONS ON THE RELEASE OF HISTAMINE BY MAST CELLS
por: Fawcett, Don W.
Publicado: (1954)

Identification of a Leukemia-Initiating Stem Cell in Human Mast Cell Leukemia
por: Eisenwort, Gregor, et al.
Publicado: (2019)

Influence of MRI contrast media on histamine release from mast cells
por: Kun, Tomasz, et al.
Publicado: (2012)

Role of protein phosphatases inhibitors on the histamine release and the functional desensitization in human lung mast cells
por: Bastan, Reza, et al.
Publicado: (2014)

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia
por: Cerny-Reiterer, Sabine, et al.
Publicado: (2014)

MAST CELL DEGRANULATION AND HISTAMINE RELEASE OBSERVED IN A NEW IN VITRO SYSTEM
por: Lagunoff, David, et al.
Publicado: (1960)

Massive release of the histamine‐degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients
por: Boehm, Thomas, et al.
Publicado: (2019)

Agarwood Inhibits Histamine Release from Rat Mast Cells and Reduces Scratching Behavior in Mice: Effect of Agarwood on Histamine Release and Scratching Behavior
por: Inoue, Eiji, et al.
Publicado: (2016)

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia
por: Cerny-Reiterer, Sabine, et al.
Publicado: (2014)

MAST CELLS AS SOURCES OF TISSUE HISTAMINE
por: Graham, Helen Tredway, et al.
Publicado: (1955)

Imaging of Canine Neoplastic Reproductive Disorders
por: Russo, Marco, et al.
Publicado: (2021)

Activation of basophil and mast cell histamine release by eosinophil granule major basic protein
Publicado: (1983)

Stimulated release of histamine by a rat mast cell line is inhibited during mitosis
Publicado: (1984)

Histamine and TNF-α release by rat peritoneal mast cells stimulated with Trichomonas vaginalis
por: Im, S.J., et al.
Publicado: (2011)

Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues
por: Valent, Peter, et al.
Publicado: (2020)

TEMPERATURE DEPENDENCE OF MAST CELL HISTAMINE SECRETION
por: Lagunoff, David, et al.
Publicado: (1974)

Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population
por: Graf, Irene, et al.
Publicado: (2022)

Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56(bright) NK cell subpopulations in patients with acute myeloid leukemia and supports their activation
por: Cuapio, Angélica, et al.
Publicado: (2016)

Induction of histamine release in vitro from rat peritoneal mast cells by extracts of grain dust.
por: Warren, C P, et al.
Publicado: (1986)

Stabilizing histamine release in gut mast cells mitigates peripheral and central inflammation after stroke
por: Conesa, Maria P. Blasco, et al.
Publicado: (2023)

Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib
por: Maffei, Rossana, et al.
Publicado: (2015)

The PI3-Kinase/mTOR-Targeting Drug NVP-BEZ235 Inhibits Growth and IgE-Dependent Activation of Human Mast Cells and Basophils
por: Blatt, Katharina, et al.
Publicado: (2012)

Mast cell degranulation and histamine release during A/H5N1 influenza infection in influenza-sensitized mice
por: Desheva, Yulia, et al.
Publicado: (2020)

Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A(2)
por: Wei, Ji-Fu, et al.
Publicado: (2009)

Histamine Released From Skin-Infiltrating Basophils but Not Mast Cells Is Crucial for Acquired Tick Resistance in Mice
por: Tabakawa, Yuya, et al.
Publicado: (2018)

Mast Cell-Derived Histamine Mediates Cystitis Pain
por: Rudick, Charles N., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fdnvod7ip13fpee6ho559gi45k